Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions
| Autor: | Jee Sun Min, Jung Bae Park, Soo Kyung Bae, Doo-Yeoun Cho, Su Jeong, Kee Dong Yoon, Doyun Kim, Yu Fen Zheng |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Male Pharmacology Toxicology digestive system 030226 pharmacology & pharmacy Rats Sprague-Dawley 03 medical and health sciences Inhibitory Concentration 50 0302 clinical medicine Non-competitive inhibition Biotransformation In vivo Gallic Acid Animals Humans Drug Interactions Gallotannin Enzyme Inhibitors Glucuronosyltransferase Intestinal Mucosa IC50 chemistry.chemical_classification Chemistry Plant Extracts General Medicine Metabolism In vitro Hydrolyzable Tannins Intestines Isoenzymes Arctostaphylos 030104 developmental biology Glucose Area Under Curve Microsomes Liver Female sense organs Glucuronide Food Science |
| Zdroj: | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 120 |
| ISSN: | 1873-6351 |
| Popis: | Uva-ursi leaf is widely used to treat symptoms of lower urinary tract infections. Here, we evaluated the in vitro inhibitory effects of uva-ursi extracts on 10 major human UDP-glucuronosyltransferases (UGT) isoforms. Of the 10 tested UGT isoforms, uva-ursi extracts exerted the strongest inhibitory effect on UGT1A1-mediated β-estradiol 3-glucuronidation with the lowest IC50 value of 8.45 ± 1.56 μg/mL. To identify the components of uva-ursi extracts showing strong inhibitory effects against UGT1A1, the inhibitory effects of nine major constituents of the extracts were assessed. Among the tested compounds, gallotannin exerted the most potent inhibition on UGT1A1, followed by 1,2,3,6-tetragalloylglucose; both demonstrated competitive inhibition, with Ki values of 1.68 ± 0.150 μM and 3.55 ± 0.418 μM. We found that gallotannin and 1,2,3,6-tetragalloylglucose also inhibited another UGT1A1-specific biotransformation, SN-38-glucuronidation, showing the same order of inhibition. Thus, in vitro UGT1A1 inhibitory potentials of uva-ursi extracts might primarily result from the inhibitory activities of gallotannin and 1,2,3,6-tetragalloylglucose present in the extracts. However, in rats, co-administration with uva-ursi extracts did not alter the in vivo marker for UGT1A1 activity, expressed as the molar ratio of AUCSN-38 glucuronide/AUCSN-38, because plasma concentrations of gallotannin and 1,2,3,6-tetragalloylglucose may be too low to inhibit the UGT1A1-mediated metabolism of SN-38 in vivo. The poor oral absorption of gallotannin and 1,2,3,6-tetragalloylglucose in uva-ursi extracts might cause the poor in vitro-in vivo correlation. These findings will be helpful for the safe and effective use of uva-ursi extracts in clinical practice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect